The survival and cost-effectiveness analysis of adjunctive Chinese medicine therapy for patients with non-small cell lung cancer: a nationwide cohort study in Taiwan

Overview of attention for article published in Frontiers in Pharmacology, June 2024

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (64th percentile)

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 17 followers.

RT @BioMedHack: Discover how adjunctive Chinese medicine enhances survival outcomes in non-small cell lung cancer, with positive cost-effec…

Discover how adjunctive Chinese medicine enhances survival outcomes in non-small cell lung cancer, with positive cost-effectiveness. #NSCLC #ChineseMedicine. https://t.co/Hdmt0ixZh2 | Follow @biomedhack for #biohacking news to help you live healthier and l

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.